Clinical trial
TREATMENT RESISTANCE FOLLOWING ANTI-CANCER THERAPIES (TRANSLATE)
NCT04436120 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TREATMENT RESISTANCE FOLLOWING ANTI-CANCER THERAPIES (TRANSLATE)
- Lead sponsor
- Pfizer
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 13, 2019
- Completion date
- December 14, 2020
- Enrollment
- 38 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.